OPEN LABEL 8-WEEK STUDY OF PRAZOSIN USE IN ADULTS WITH ANXIETY DISORDERS
- Registry ID
- PRA2051N
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Study type
- INTERVENTIONAL
- Sponsor
- UNIVERSITY OF MANITOBA
- Start date
- 2019-05-01
- Last update
- 2018-02-02
Conditions
Related clinical trials
- PSILOCYBIN-ASSISTED EXISTENTIAL, ATTACHMENT AND RELATIONAL (PEARL) THERAPY FOR CAREGIVERS OF PATIENTS WITH ADVANCED CANCER: A PHASE II OPEN-LABEL TRIAL
- A PHASE 2A, PLACEBO-CONTROLLED RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND PRELIMINARY EFFICACY OF PSILOCYBIN ORAL SOLUTION IN ADULTS WITH GENERALIZED ANXIETY DISORDER
- A RANDOMIZED PLACEBO-CONTROLLED TRIAL OF SERTRALINE VS. PLACEBO IN THE TREATMENT OF ANXIETY IN CHILDREN AND ADOLESCENTS WITH NEURODEVELOPMENTAL DISORDERS
- A PHASE 2A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTI-CENTER STUDY INVESTIGATING THE EFFICACY, SAFETY, AND TOLERABILITY OF JNJ-42165279 IN SUBJECTS WITH SOCIAL ANXIETY DISORDER
View on source registry